CREB1 and cerebral malaria: In recent work on liraglutide treatment in experimental cerebral malaria—a neuropathology with preserved mitochondrial function and without frank reactive oxygen species damage—liraglutide is not protective and does not activate the CREB system (DellaValle et al., 2016).